The Human Genome Project, launched in 1990 and completed in 2003, also moved the needle. Scientists had successfully ...

Every hospital shelf and pharmacy counter depends on an invisible global current, the pharmaceutical supply chain. Yet this ...

Harmony Biosciences Holdings (HRMY) is in the spotlight after announcing that its Phase 3 RECONNECT study for ZYN002 in Fragile X syndrome did not meet its main goal, citing higher than expected ...

Researchers at Moffitt Cancer Center have reported encouraging results from a phase 1B clinical trial showing that the immunotherapy drug avelumab, when combined with whole brain radiotherapy, may ...

The medical establishment and mainstream media are uniting against the Trump administration's re-purposing of an inexpensive drug to treat an epidemic, calling it "unproven," not "backed by science," ...

BETHESDA, Md. — Exactly one year ago, in these pages, I implored Congress to receive classified testimony from me about State Department and CIA efforts to cover up evidence and intelligence of the so ...

Nephrotic syndrome is a clinical entity defined by heavy proteinuria, hypoalbuminemia, hyperlipidemia, and edema, stemming from various glomerular diseases. Diagnosis requires a comprehensive ...

PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced topline results from its Phase 3 registrational clinical trial (the RECONNECT Study) of ...

The U.S. Food and Drug Administration has granted accelerated approval to Forzinity (elamipretide) injection as the first treatment for Barth syndrome. Barth syndrome is a rare, serious, and ...

Walker Burger always loved baseball, but attending the games of his favorite team, the Atlanta Braves, used to be a physical challenge. In fact, every form of exercise was difficult. Burger, 35, has a ...